Andal, Akila S.

HRN: 22-23-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
AMPICILLIN 250MG (VIAL)
11/21/2022
11/28/2022
IVT
220 Mg
6 Hrs
AGE W/ Moderate Dehydration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: